A recent BMC Public Health study analyzes self-monitoring data from Chinese adults who participated in a group weight loss intervention using a mixed-methods approach. Study: Why more successful? An ...

Share on Pinterest The Signos system can be used alone, in combination with, or after GLP-1 drugs or bariatric surgery. Photography courtesy of Signos The FDA cleared the first glucose monitoring ...

In a significant development for weight management, the Food and Drug Administration (FDA) announced Wednesday its approval of the first-ever glucose monitoring system designed specifically for weight ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. Technology-based self-monitoring showed a “strong and ...

Self-monitoring dietary intake is a critical component of family-based intensive health behavior and lifestyle treatment for pediatric obesity, but adherence rates are often low. This study identifies ...

Utilization of GLP-1s, short for glucagon-like peptide 1 agonists, has been building as the drugs, originally approved for diabetes, are used more frequently for weight loss. Insurers have been ...

The Food and Drug Administration approved the first-ever glucose monitoring system specifically for weight management from the startup Signos, a new option for Americans to manage their weight. Any ...

The FDA has approved Signos, an AI-powered app that uses continuous glucose monitoring to guide weight loss and personalized nutrition. Cheaper than GLP-1 drugs, Signos offers real-time feedback on ...